Adjuvant and Formulation Considerations for a Subunit Blood-Stage Malaria Vaccine
22 Pages Posted: 14 Jun 2019
Date Written: August 15, 2012
Abstract
Protection against malaria from a vaccine requires modulation of the immune response to malaria antigens. This modulation by pathogen-derived molecules is explored in this study. Human immune cells synergistically express signaling proteins when stimulated by certain combinations of pathogen-derived molecules. Some of these expression profiles indicate a Th1-mediated immune response, which may be the immune response needed for the next-generation malaria of vaccines, in terms of effectiveness.
Keywords: malaria, vaccine, public health
Suggested Citation: Suggested Citation
Chang, Martin and Chang, Martin, Adjuvant and Formulation Considerations for a Subunit Blood-Stage Malaria Vaccine (August 15, 2012). Available at SSRN: https://ssrn.com/abstract=3397972 or http://dx.doi.org/10.2139/ssrn.3397972
Do you have a job opening that you would like to promote on SSRN?
Feedback
Feedback to SSRN